<DOC>
	<DOCNO>NCT02935309</DOCNO>
	<brief_summary>This research study design see Capecitabine Lenvatinib combination external radiation therapy effective treat locally advanced rectal adenocarcinoma patient yet surgery , best dosage .</brief_summary>
	<brief_title>Capecitabine Lenvatinib With External Radiation Rectal Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Lenvatinib</mesh_term>
	<criteria>Histologically ( archival tissue ) confirm adenocarcinoma rectum begin within 12 cm anal verge determine sigmoidoscopy and/or colonoscopy evidence distant metastasis . Locally advanced rectal cancer determine follow feature : 1 . ) Fixed immobile tumor physical exam and/or ; 2 . ) T3 disease invasion muscularis propria define transrectal ultrasound , CT MRI ; 3 . ) T4 disease invasion adjacent structure pelvic sidewall , sacrum , pelvis , bladder and/or prostate determine appropriate imaging modality ultrasound , CT MRI ; 4 . ) Any T + N CT scan/MRI transrectal ultrasound . Age equal great 18 year Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 1 . Adequate bone marrow , liver renal function . Women childbearing potential must negative serum pregnancy test perform within 7 day prior start treatment . Women childbearing potential men must agree use adequate contraception ( barrier method birth control ) prior study entry duration study participation . Men use adequate birth control least 3 month last administration lenvatinib . Ability understand willingness sign write informed consent . A sign informed consent must obtain prior study specific procedure . Cardiac disease : Congestive heart failure &gt; class II New York Heart Association ( NYHA ) . Participants must unstable angina ( anginal symptom rest ) new onset angina ( begin within last 3 month ) myocardial infarction within past 6 month . Previous pelvic irradiation therapy . Cardiac ventricular arrhythmia require antiarrhythmic therapy . Uncontrolled hypertension define systolic blood pressure &gt; 150 mmHg diastolic pressure &gt; 90 mmHg , despite optimal medical management . Known human immunodeficiency virus ( HIV ) infection chronic hepatitis B C. Active clinically serious infection &gt; CTCAE Grade 2 . Thrombotic embolic event cerebrovascular accident include transient ischemic , attack , deep vein thrombosis ( DVT ) within past 6 month . Bleeding thrombotic disorder use anticoagulant , warfarin , similar agent require therapeutic international normalize ration ( INR ) monitoring . ( Treatment low molecular weight heparin ( LMWH ) allow ) . Active malignancy except nonmelanoma skin cancer situ cervical cancer treat nonpelvic cancer patient continuously disease free 3 year . Marked baseline prolongation QT/QTc interval ( QTc interval ≥ 500 msec ) use Fridericia method ( QTc = QT/RR0.33 ) QTc analysis . Greater 30 mg/dL urine analysis . Patients &gt; 30 mg/dL urine analysis urine analysis undergo 24hour urine collection quantitative assessment proteinuria . Patients 24hour protein ≥1 g/24 hour ineligible . Needing medical attention serious bleed past 4 week . Previous chemotherapy except antiangiogenic agent tyrosine kinase inhibitor ( TKI ) allow long 5 year . Major surgery within 3 week start chemotherapy . Evidence history bleed diathesis . Use St. John 's Wort rifampin . Known suspected allergy lenvatinib agent give course trial . Any condition impair participant 's ability swallow whole pill . Any malabsorption problem . Medical need continue use potent inhibitors/inducers CYP3A4 . Creatinine clearance within study guideline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>rectum</keyword>
	<keyword>transrectal</keyword>
	<keyword>carcinoma</keyword>
</DOC>